Pharma Industry News
PREZISTA®* Now Approved as Part of Combination Therapy for Pediatric Patients Six Years of Age and Older with HIV(Feb 9, 2010)
Toronto, ON (February 9, 2010) – Tibotec, a division of Janssen-Ortho Inc., announced that Health Canada has approved PREZISTA® (darunavir) for use in children with HIV between the ages of six and 18, dosed twice daily in combination with ritonavir and other antiretroviral agents.
Online, Personalized STD Test Recommendation is the First Developed by a National Team of Academic and Medical Experts Targeted to College Students and Young Adults
CHICAGO, Feb. 9 /PRNewswire/ -- STDUniversity.org is the first website to provide an interactive, personalized STD test recommendation developed by academic and medical experts. This expert-based tool incorporates screening guidelines from the Centers for Disease Control and Prevention (CDC), U.S. A
Medical, Security and Crisis Response Experts Host Webinar on Haiti Earthquake
TREVOSE, Penn., Feb. 9 /PRNewswire/ --
WHO: International SOS, the world's leading provider of integrated
medical, international healthcare and security assistance services.
Keynote Speakers:
-- Members of the crisis management team formed in r
Satellite Healthcare's Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses' Association
MOUNTAIN VIEW, Calif., Feb. 9 /PRNewswire/ -- Sheila Doss, BSN, RN, CNN, CCRA of San Jose, California, has been re-elected Western Chapters Coordinator-Elect (CCE) of the American Nephrology Nurses' Association (ANNA) for 2010-11.
Doss, Nursing Director of Research of Satellite Healthcare will assu
Analysts: If Health Reform Fails, Expect More Industry Mergers
News outlets report on how the fate of the health care overhaul might affect health industry mergers and biotech firms...
Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps
PEORIA, Ariz., Feb. 9 /PRNewswire/ -- A leading clinical research center in Peoria has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women
National Heart Failure Awareness Week February 14-20, 2010: Visit www.abouthf.org to Learn More About Heart Failure
NEW YORK, Feb. 9 /PRNewswire/ -- National Heart Failure Awareness Week is set for February 14-20. This is a time for physicians and other health providers to remind patients with heart failure, those at risk and family members of patients how to best manage this syndrome, what heart failure means, t
Gerresheimer Achieves Sales Target for 2009
DUSSELDORF, Germany, February 9 /PRNewswire-FirstCall/ --
- Profit Margin Better Than Expected
- Sales on like-for-like basis almost at prior year level (-1.5 percent)
- Adjusted EBITDA margin of 19.2 percent (on like-for-like basis) better
than expected
- CEO Dr. Axel Her
